Jingxin Li

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Fengcai Zhu, Fanyue Meng, Jingxin Li et al. · The Lancet · 2013 · 390 citations

Veterinary Medicine, Immunology, Pediatrics +12

Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial

Ming Zeng, Xuhu Mao, Jingxin Li et al. · The Lancet · 2015 · 294 citations

Veterinary Medicine, Immunology, Pediatrics +12

A GABAergic system in airway epithelium is essential for mucus overproduction in asthma

Yun‐Yan Xiang, Shuhe Wang, Mingyao Liu et al. · Nature Medicine · 2007 · 206 citations

Life Sciences, Pharmacology, Physiology +12

An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Yiyue Ge, Tingzhong Tian, Suling Huang et al. · Signal Transduction and Targeted Therapy · 2021 · 204 citations · Full text

Pharmacy, Bioinformatics, Pharmacology +17